<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>20648464</identifier>
<setSpec>1576-6578</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Alcauter-Solórzano, Sarael</dc:author>
<dc:author>Alonso-Vilatela, M Elisa</dc:author>
<dc:author>Fermín-Delgado, Rafael O</dc:author>
<dc:author>Barrios, Fernando A</dc:author>
<dc:author>Pasaye-Alcaraz, Erick H</dc:author>
<dc:author>Salgado-Lujambio, Perla</dc:author>
<dc:author>Alvarado-Alanis, Patricia</dc:author>
<dc:description xml:lang="en">INTRODUCTION Huntington's disease is an hereditary autosomic-dominant neurodegenerative disorder, characterized by motor, cognitive and psychiatric symptoms. AIM To quantify differences in N-acetylaspartate, creatine and choline in caudate nucleus, putamen and occipital cortex of patients with Huntington's disease, symptomatics and asymptomatics. SUBJECTS AND METHODS Hydrogen magnetic resonance spectroscopy was performed with a 3 T scanner in 10 Huntington's disease gene-tested subjects, included in three groups: negative (control), positive symptomatics and positive asymptomatics. Data was quantified with LCModel and analyzed with ANOVA and Fisher tests. RESULTS Symptomatic patients showed decreased creatine and N-acetylaspartate in the three regions, and decreased choline only in putamen (p &lt; 0.05). Choline difference was found between symptomatics and asymptomatics in the caudate nucleus (p &lt; 0.05). CONCLUSIONS Results may reflect neuronal dysfunction and suggest that creatine and choline may serve as markers for Huntington's disease progression.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2010 Aug 16 </dc:date>
<dc:title xml:lang="es">Espectroscopia cuantitativa de hidrógeno por resonancia magnética de 3 T en pacientes sintomáticos y asintomáticoscon enfermedad de Huntington.</dc:title>
<dc:title xml:lang="en">[Hydrogen magnetic resonance quantitative spectroscopy at 3 T in symptomatic and asymptomatic Huntington's disease patients].</dc:title>
<dc:publisher>Revista de neurologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
